UMR Right
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
861Activities
Technologies
Entity types
Location
Denfert Rochereau, 25000 Besançon, France
Besançon
France
Employees
Scale: 51-200
Estimated: 36
Engaged corporates
7
3 1Added in Motherbase
11 months, 4 weeks ago
deeptech Value proposition
We are an immunology lab pursuing innovative ways to control cancer as well as inflammation in diseases and graft.
UMR Right is a joint research unit affiliated to INSERM (National Institute of Health and Medical Research), EFS (French Blood Bank Institute) and the University of Franche-Comté.
We develop basic, translational and clinical research programs to improve knowledge, diagnosis and treatments in the context of cancer immunity and immunotherapy (Team: TIMC), and organ and cell transplantation, inflammatory and autoimmune diseases (Team: ATI).
Our main goals:
- Characterize the pathogenic or protective immune responses involved in these diseases in order to identify new therapeutic targets and biomarkers
- Transfer these advances to the clinic by developing new immunotherapeutic (cell therapies, vaccines, immunomodulators) and improving prognostic/predictive values.
UMR Right brings together scientists and clinicians with complementary expertise in immunology, oncology, transplantation, autoimmunity, nephrology and genomics.
UMR Right Teams:
TIMC: This team focuses its research on understanding the interactions between T lymphocytes, the tumor and its microenvironment in order to develop innovative immunotherapies (CAR-T, vaccines) and select the right treatment for the right patient (biomarkers).
ATI: This team focuses its research on the study of the immunological mechanisms at the origin of transplant rejection, those involved in the initiation and maintenance of autoimmune and/or inflammatory pathologies. This better understanding aims at the development of adapted and innovative therapeutic approaches.
UMR Right is part of the "LipSTIC Lipoprotéines et Santé : prévention et Traitement des maladies Inflammatoires et du Cancer" Laboratory of Excellence.
UMR Right is part of the OPALE Carnot Institute for the research and development of innovative solutions for the diagnosis, treatment and monitoring of patients in the field of leukemia.
Concerned about the quality of its work, our lab has been ISO:9001 certified (2012).
Immunology, Immunotherapy, Cancer, Graft, Tumor, Cell Therapy, CAR-T Cells, Vaccine, GvHD, Transplantation, Inflammation, Microenvironment, Biomarkers, Biotherapy, and TransplantationOriginal language
We are an immunology lab pursuing innovative ways to control cancer as well as inflammation in diseases and graft.
UMR Right is a joint research unit affiliated to INSERM (National Institute of Health and Medical Research), EFS (French Blood Bank Institute) and the University of Franche-Comté.
We develop basic, translational and clinical research programs to improve knowledge, diagnosis and treatments in the context of cancer immunity and immunotherapy (Team: TIMC), and organ and cell transplantation, inflammatory and autoimmune diseases (Team: ATI).
Our main goals:
- Characterize the pathogenic or protective immune responses involved in these diseases in order to identify new therapeutic targets and biomarkers
- Transfer these advances to the clinic by developing new immunotherapeutic (cell therapies, vaccines, immunomodulators) and improving prognostic/predictive values.
UMR Right brings together scientists and clinicians with complementary expertise in immunology, oncology, transplantation, autoimmunity, nephrology and genomics.
UMR Right Teams:
TIMC: This team focuses its research on understanding the interactions between T lymphocytes, the tumor and its microenvironment in order to develop innovative immunotherapies (CAR-T, vaccines) and select the right treatment for the right patient (biomarkers).
ATI: This team focuses its research on the study of the immunological mechanisms at the origin of transplant rejection, those involved in the initiation and maintenance of autoimmune and/or inflammatory pathologies. This better understanding aims at the development of adapted and innovative therapeutic approaches.
UMR Right is part of the "LipSTIC Lipoprotéines et Santé : prévention et Traitement des maladies Inflammatoires et du Cancer" Laboratory of Excellence.
UMR Right is part of the OPALE Carnot Institute for the research and development of innovative solutions for the diagnosis, treatment and monitoring of patients in the field of leukemia.
Concerned about the quality of its work, our lab has been ISO:9001 certified (2012).
Accueil - Right
https://umr-right.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Région Bourgogne-Franche-Comté National and local authorities, Government Administration | Région Bourgogne-Franche-Comté National and local authorities, Government Administration | Other 2 Aug 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 1 Nov 2023 | | |
 PMT Public business cluster, French Cluster, Civic and Social Organizations | PMT Public business cluster, French Cluster, Civic and Social Organizations | Other 22 Dec 2023 | | |
 SAYENS Research, Startup accelerator & VC, Research Services | SAYENS Research, Startup accelerator & VC, Research Services | Other 11 Apr 2024 | | |
 Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 1 Nov 2023 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 1 Nov 2023 | | |
 Agence Economique Régionale Bourgogne-Franche-Comté - AER BFC / AERBFC Government Administration | Agence Economique Régionale Bourgogne-Franche-Comté - AER BFC / AERBFC Government Administration | Other 14 May 2023 | | |